News

A study released today indicates that burden of quality measures may be counterproductive in patient care, suggests possible need for intervention

Data published in the New England Journal of Medicine Catalyst reported that MedPearl, a Providence-developed platform, improves primary care clinician productivity, decreases time waste.

Providence announced results for the three months ended June 30, 2024, which showed continued improvement in operating performance.

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

Providence has made considerable progress in restoring services since last Friday

Our IT teams have been working overnight to respond to the issue and have restored key functionality in the Epic electronic health record.

The Providence St. Joseph Health Board of Directors announced that Providence Chief Operating Officer Erik Wexler has been named the health system’s next president and chief executive officer.

Supporting people in times of need, remote capabilities have enabled Providence chaplains to care for over 1,000 people since 2022.

Over the next three years, this study seeks to identify the patterns of access and use of cancer services among high-risk patients to understand how to guide them toward quality care.

Investments focus on addressing social determinants of health and ensuring continued access to vital care for those in need

Network members focus on helping caregivers address community health needs through service, advocacy, and giving.

CHA has named Providence Chief Communication Officer Orest Holubec as vice chairperson/chairperson-elect of the CHA Board of Trustees, while Chief Legal Officer Anna Newsom was elected to the Board.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.

The 2023 Providence Research Network annual report, released on Clinical Trials Day 2024, highlights the breadth and impact of research at Providence.

With a continued focus on strategies for recovery and renewal, Providence reported a positive first quarter.

After 45 years in health care, including 17 with the Providence family of organizations, Rod Hochman, M.D., announced that he will retire as president and CEO of Providence at the end of 2024.

Providence has been presented with 55 Practice Greenhealth Environmental Excellent Awards in recognition of exceptional environmental stewardship across the organization.

Over 50,000 donors to Providence foundations fund critical research, clinical breakthroughs, patient support services and technological advances in urban and rural communities across the Western U.S.

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.